125I-Gd-Abeta30

N/A

Report date: 2025/02/06 10:15:58
NME

Base Information

Drug Name125I-Gd-Abeta30
Drug Alias Name125I-Gd-Abeta30(125)I-Gd[N-4ab/Q-4ab]Abeta 30
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionMagnetic resonance imaging enhancers
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A